What we publish

• Research explainers and conservative summaries of primary literature.
• Vendor performance analyses: incident timelines, delivery reliability snapshots, support behavior—evidence only.
• Safety/legal context explainers (educational; not medical or legal advice).
• Methodology audits and data deep-dives.
• Forum-driven syntheses consolidating multiple credible reports.

Standards (read first)

• Evidence-first: primary > reputable secondary > community signals (as signals only).
• No medical advice. Discuss ranges from sources; label uncertainty.
• Independence: coverage includes non-affiliates; partnerships do not decide topics. Scam reports may cover companies that offered partnerships.
• Originality: original work or substantially new analysis.
• COI disclosure: declare affiliations or past employment.
• Citations: link sources inline; attach redacted receipts/screens where relevant.
• Edits & fact-check: submissions may be edited for clarity, accuracy, and house style.

What we don’t publish

• Promotional pieces, link spam, or undisclosed conflicts.
• Unverifiable claims, speculation presented as fact, or dosage “advice.”

How to pitch (24h reply)

Send via /contact (or post in the forum and tag “Editorial Pitch”). Include:

• Working title + one-sentence thesis
• Why now / what’s new
• Evidence list (sources, datasets, receipts)
• Outline (5–8 bullets)
• COI disclosure (if any)
• Your experience (1–2 lines; forum handle ok)

Format & rights

• Format: Google Doc link or Markdown; images as WebP/PNG with alt text.
• Attribution: byline, short bio, and optional link to your forum profile.
• Rights: you grant ModafinilTalk a non-exclusive license to publish and maintain an archive copy. Cross-posting elsewhere requires a link back and a note that the canonical version appears on ModafinilTalk.
• Compensation: no sponsored posts; occasionally we commission data-backed deep dives—note in your pitch if you’re open to commissioning.